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through bedside assessment by our addiction clinician. These patients were
subsequently assessed for initiation and/or optimization of MOUD.
CONCLUSIONS: We developed two complementary EHR screening
methods to identify patients with OUD and housing insecurity. Approximately
30% of the patients from this dual screen were considered likely to have OUD
& housing insecurity upon further review by a nurse. After clinical assessment
by an addictions provider, 33% of these patients were confirmed to have
housing insecurity and OUD. Automated strategies may help health systems
identify at-risk patients.
LEARNING OBJECTIVE #1: To create a prospective screening method to
identify patients with suspected opioid use disorder (OUD) and housing
insecurity.
LEARNING OBJECTIVE #2: To connect patients with OUD and housing
insecurities to an addictions provider for initiation and optimization of medications for opioid use disorder (MOUD) .
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BACKGROUND: Interhospital transfer (IHT), which is often performed to
provide patients with necessary procedural and specialized care, is a common
occurrence in modern healthcare. Racial/ethnic inequities in IHT have been
described using nationally representative data, however such inequities have
not been characterized at a more local level, which can provide more granular
data to adjust for possible confounding. The purpose of this study was to
determine if there were racial/ethnic inequities in IHT for common medical
conditions within our major academic healthcare system.
METHODS: We performed a retrospective matched cohort study of patients
admitted to general medicine services at community hospitals within our
system. We included adult patients age ≧ 18 with all medical diagnoses
admitted to these hospitals between June 2015 to December 2018 and excluded
intensive care unit patients. The outcome was IHT to the tertiary care hospitals
within our system. The primary predictor of interest was Black race and Latinx
ethnicity. We used a matched cohort study design in which one Black patient
with an index admission to one of our system’s community hospitals was
matched to three White patients based on their origin hospital, age within five
years and similar electronic cardiac arrest risk triage (eCART) score on
admission. The same design was then used for Latinx and White patients.
Following this match, rates of transfer were compared between the groups.
This was done using a series of conditional logistic regression models, including an unadjusted model and a model which adjusted for patient-level
demograhpic and clinical covariates. Analyses were considered significant at
a 2-sided p-value of 0.05.
RESULTS: Among the 72,113 admissions included in the cohort, 1,209
(2.1%) of White, 132 (2.3%) of Black and 138 (2.1%) of Latinx patients
underwent IHT. After matching, compared to White patients, Black and Latinx
patient had significantly higher rates of Medicaid as primary insurance and of
being in the lowest zip code median income quartile. There was a nonsignificant signal toward lower odds of IHT for Black compared to White
patients in unadjusted (OR 0.86, 95% CI 0.70-1.05, p=0.14) and adjusted (OR
0.80, 95% CI 0.62-1.02; p=0.074) models. There was no significant difference
for Latinx compared to White patients.
CONCLUSIONS: Black patients had a non-significant signal toward lower
odds of IHT to tertiary hospitals within our system compared to White patients
after adjusting for patient clinical and demographic variables. There are several
potential explanations for these findings, including provider bias toward Black
patients. Our findings emphasize the need for better understanding of transfer
practices so that such inequities may be eliminated.
LEARNING OBJECTIVE #1: To idenitify potential racial and ethnic inequities in specialty care access
LEARNING OBJECTIVE #2: To understand the role that provider bias may
play in decision-making surrounding the triage of patients to higher levels of care.
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BACKGROUND: The COVID-19 pandemic has resulted in over 1 million
deaths globally. Prognostic tools to identify high risk patients are crucial to
guide resource allocation efforts. We aimed at developing a risk assessment
tool for patients with COVID-19 based on the risk factors with most significant
effect on hospital admission and in-hospital mortality
METHODS: We performed a retrospective analysis of patients with positive
COVID-19 presenting in between 3/31/2020 – 5/15/2020 at Beaumont
Health’s 8 emergency departments (ED). Data was abstracted using automated
reports. The electronic health record (HER) embedded risk score previously
externally validated was modified based on risk factors, with different points
given those that were statistically significant. Two outcome variables were
measured, both using a yes/no binary scale: hospital admission and in-hospital
mortality. Hospital admission, on the first encounter to the ED, was evaluated
for the entire cohort, while mortality was evaluated only for inpatients
discharged prior to 5/12/2020. Descriptive statistics, univariate/multivariate
analyses by logistic regression were performed and presented in terms of
Adjusted Odds Ratios (AOR) with corresponding 95% confidence intervals
and P-Values. Any P-Values < 0.05 were considered as statistically significant
associations.
All analysis was done in SAS 9.4 (SAS Institute Inc. Cary, NC).
RESULTS: 2,735 encounters were extracted from EHR. 68.06% were hospital admissions and 9.97% experienced in-hospital mortality. 61.23% were <69
years old. 58.07% had hypertension (HTN), 46.29% had chronic pulmonary
disease (CPD), 37.81% had diabetes (DM), and 6.71% had end-stage renal
disease (ESRD). Mean length of stay was 8.43 days. In the multivariate model
to predict admission, ESRD (AOR 1.97), liver disease (AOR 7.77), CPD
(AOR 1.63), DM (AOR 1.70), HTN (AOR 1.97) and nursing home residence
(NH) (AOR 1.90) were independently associated with admission. For prediction of in-hospital mortality in the multivariate model, CPD (AOR 2.35), and
NH (AOR 1.58) were significantly associated with in-hospital mortality. The
modified risk score recognized the statistically significant comorbid conditions
and attributed 0 points to non-significant values. The cross-validated CStatistics for the modified risk score model showed good discrimination for
both hospital admission (C=0.72 vs 0.70) and in-hospital mortality (C=0.74 vs
0.70) when compared to the automatically generated risk tool for this cohort.
CONCLUSIONS: The modified risk score model created using statistically
significant risk factors yielded a better scoring system than the scoring system
automatically generated in Epic. This risk scoring model may help predict
hospital admissions and in-hospital mortality for COVID-19 patients. Further
external validation in a different cohort is recommended.
LEARNING OBJECTIVE #1: Timely identification of COVID 19 patients
at higher risk for hospital admission.
LEARNING OBJECTIVE #2: Recognition of predictive factors of poor
outcome in COVID 19 patients.
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BACKGROUND: Medically complex patients with disability have among
the highest 30-day readmissions. However, physical functioning is neither
readily available in claims data nor included in CMS risk-adjustment models.

